What is the share price of Torrent Pharmaceuticals Ltd (TORNTPHARM) today?
The share price of TORNTPHARM as on 18th September 2026 is ₹4840. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The past returns of Torrent Pharmaceuticals Ltd (TORNTPHARM) share are- Past 1 week: -1.44%
- Past 1 month: -1.22%
- Past 3 months: 8.87%
- Past 6 months: 12.84%
- Past 1 year: 35.67%
- Past 3 years: 156.84%
- Past 5 years: 216.56%
What are the peers or stocks similar to Torrent Pharmaceuticals Ltd (TORNTPHARM)?
The peers or stocks similar to Torrent Pharmaceuticals Ltd (TORNTPHARM) include:What is the dividend yield % of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The current dividend yield of Torrent Pharmaceuticals Ltd (TORNTPHARM) is 0.70.What is the market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹184098.04 Cr as of 18th September 2026.What is the 52 week high and low of Torrent Pharmaceuticals Ltd (TORNTPHARM) share?
The 52-week high of Torrent Pharmaceuticals Ltd (TORNTPHARM) is ₹5250 and the 52-week low is ₹3480.60.What is the PE and PB ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM) stock?
The P/E (price-to-earnings) ratio of Torrent Pharmaceuticals Ltd (TORNTPHARM) is 85.10. The P/B (price-to-book) ratio is 10.47.Which sector does Torrent Pharmaceuticals Ltd (TORNTPHARM) belong to?
Torrent Pharmaceuticals Ltd (TORNTPHARM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares?
You can directly buy Torrent Pharmaceuticals Ltd (TORNTPHARM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Torrent Pharmaceuticals Ltd
TORNTPHARM Share Price
NSE₹4,840.001.20% (-59.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TORNTPHARM Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TORNTPHARM Performance & Key Metrics
TORNTPHARM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 85.39 | 10.47 | 0.70% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.16 | 5.92 | 0.48% |
81%
Analysts have suggested that investors can buy this stock
from 27 analysts
Price Upside
Earnings Growth
Rev. Growth
TORNTPHARM Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
SUNPHARMA
PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
ZYDUSLIFE
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
AUROPHARMA
PE Ratio
28.47
28.47
1Y Return
53.60%
53.60%
Buy Reco %
72.00
72.00
TORNTPHARM Sentiment Analysis
TORNTPHARM Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TORNTPHARM Stock Summary · August 2026
Management’s message was that Torrent entered FY27 with stronger scale, better profitability and broad-based operating momentum, even as integration work and a few temporary disruptions will affect the next few quarters. The completed JB merger lifted consolidated revenue and operating EBITDA, with combined leverage at 2.07x net debt to EBITDA, while cost synergies are already running ahead of plan and are expected to exceed Rs 100 crore versus the original Rs 90 crore target. In the India base business, revenue reached INR2,157 crores and grew 19%, supported by 5.1% volume growth, 7.7% price growth and new products, alongside a gross margin rise to about 78% and a base business EBITDA margin of 32.8%. Management also highlighted rapid scaling in Curatio, improving JB field-force attrition, and a stronger chronic franchise, but noted that merging brands and territories could cause minor revenue disruption for 2 to 3 quarters. The semaglutide franchise faces a temporary supply issue in India and Brazil approval remains pending. Management expects the India base business to keep outperforming, the US generics business to be profitable this year, and integration effects to largely normalize by the fourth quarter.
TORNTPHARM Stock Growth Drivers
TORNTPHARM Stock Growth Drivers
6Merger Completion and Synergy Realization
Torrent Pharma has completed the JB merger, creating a larger combined platform with materially stronger
Strong India Franchise Momentum
Torrent’s India business is delivering broad-based outperformance versus the market, supported by volume, price, new
TORNTPHARM Stock Challenges
TORNTPHARM Stock Challenges
5India Semalix/semaglutide supply disruption and revenue downgrade
A supply-related disruption has materially hurt the India semaglutide franchise, reducing near-term sales and interrupting
Loss of first-mover advantage in Brazil semaglutide
The company acknowledged that it missed the chance to launch semaglutide first in Brazil, which
TORNTPHARM Forecast
TORNTPHARM Forecasts
Price
Revenue
Earnings
TORNTPHARM Share Price Forecast
TORNTPHARM Share Price Forecast
2026
Current
₹4,840.00
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹4,840.00
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TORNTPHARM Company Revenue Forecast
TORNTPHARM Company Revenue Forecast
2026
Current
₹19.18
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹19.18
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
TORNTPHARM Stock EPS (Earnings Per Share) Forecast
TORNTPHARM Stock EPS (Earnings Per Share) Forecast
2026
Current
₹63.92
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹63.92
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TORNTPHARM
TORNTPHARM
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TORNTPHARM Income Statement
TORNTPHARM Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,776.00 | 2,883.00 | 2,873.00 | 2,842.00 | 2,941.00 | 3,141.00 | 3,275.00 | 3,290.00 | 4,180.00 | 4,909.00 | ||||||||||
Operating & Other expenses | 1,862.00 | 1,955.00 | 1,950.00 | 1,895.00 | 2,019.00 | 2,146.00 | 2,232.00 | 2,225.00 | 2,907.00 | 3,278.00 | ||||||||||
EBITDA | 914.00 | 928.00 | 923.00 | 947.00 | 922.00 | 995.00 | 1,043.00 | 1,065.00 | 1,273.00 | 1,631.00 | ||||||||||
| Depreciation/Amortization | 203.00 | 197.00 | 198.00 | 199.00 | 201.00 | 201.00 | 204.00 | 206.00 | 508.00 | 593.00 | ||||||||||
| PBIT | 711.00 | 731.00 | 725.00 | 748.00 | 721.00 | 794.00 | 839.00 | 859.00 | 765.00 | 1,038.00 | ||||||||||
| Interest & Other Items | 80.00 | 75.00 | 64.00 | 57.00 | 56.00 | 56.00 | 48.00 | 45.00 | 236.00 | 305.00 | ||||||||||
| PBT | 631.00 | 656.00 | 661.00 | 691.00 | 665.00 | 738.00 | 791.00 | 814.00 | 529.00 | 733.00 | ||||||||||
| Taxes & Other Items | 182.00 | 199.00 | 208.00 | 188.00 | 167.00 | 190.00 | 200.00 | 179.00 | 165.00 | 167.00 | ||||||||||
| Net Income | 449.00 | 457.00 | 453.00 | 503.00 | 498.00 | 548.00 | 591.00 | 635.00 | 364.00 | 566.00 | ||||||||||
| EPS | 13.27 | 13.51 | 13.37 | 14.88 | 14.71 | 16.19 | 17.54 | 18.77 | 11.51 | 14.87 |
TORNTPHARM Company Updates
TORNTPHARM Stock Peers
TORNTPHARM Past Performance & Peer Comparison
TORNTPHARM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd | 85.10 | 10.47 | 0.70% |
| Sun Pharmaceutical Industries Ltd | 38.40 | 5.26 | 0.87% |
| Zydus Lifesciences Ltd | 22.96 | 3.91 | 0.09% |
| Cipla Ltd | 29.04 | 3.26 | 0.93% |
TORNTPHARM Stock Price Comparison
Compare TORNTPHARM with any stock or ETFCompare TORNTPHARM with any stock or ETF
TORNTPHARM
TORNTPHARM Holdings
TORNTPHARM Shareholdings
TORNTPHARM Promoter Holdings Trend
TORNTPHARM Promoter Holdings Trend
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TORNTPHARM Institutional Holdings Trend
TORNTPHARM Institutional Holdings Trend
No institutional holdings trend are available
TORNTPHARM Shareholding Pattern
TORNTPHARM Shareholding Pattern
TORNTPHARM Shareholding History
TORNTPHARM Shareholding History
Foreign Institutions
Mutual Funds Invested in TORNTPHARM
Mutual Funds Invested in TORNTPHARM
No mutual funds holding trends are available
Top 5 Mutual Funds holding Torrent Pharmaceuticals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8753% | Percentage of the fund’s portfolio invested in the stock 4.04% | Change in the portfolio weight of the stock over the last 3 months 0.27% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/50 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4761% | Percentage of the fund’s portfolio invested in the stock 1.23% | Change in the portfolio weight of the stock over the last 3 months 1.23% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 18/74 (+17) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4088% | Percentage of the fund’s portfolio invested in the stock 2.39% | Change in the portfolio weight of the stock over the last 3 months 2.39% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 107/141 (+28) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TORNTPHARM stock
smallcases containing TORNTPHARM stock
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Torrent Pharmaceuticals Ltd
TORNTPHARM Events
TORNTPHARM Events
TORNTPHARM Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.70%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.99 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TORNTPHARM Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.70%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.99 every year
TORNTPHARM Upcoming Dividends
TORNTPHARM Upcoming Dividends
No upcoming dividends are available
TORNTPHARM Past Dividends
TORNTPHARM Past Dividends
Cash Dividend
Ex DateEx DateMay 29, 2026
Final
Final | Div/Share: ₹9.00
Dividend/Share
₹9.00
Ex DateEx Date
May 29, 2026
Cash Dividend
Ex DateEx DateFeb 18, 2026
Interim
Interim | Div/Share: ₹29.00
Dividend/Share
₹29.00
Ex DateEx Date
Feb 18, 2026
Cash Dividend
Ex DateEx DateJun 20, 2025
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Jun 20, 2025
Cash Dividend
Ex DateEx DateJan 31, 2025
Interim
Interim | Div/Share: ₹26.00
Dividend/Share
₹26.00
Ex DateEx Date
Jan 31, 2025
Cash Dividend
Ex DateEx DateJun 21, 2024
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Jun 21, 2024
TORNTPHARM Stock News & Opinions
TORNTPHARM Stock News & Opinions
Articles & Videos
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd drops for fifth straight sessionTorrent Pharmaceuticals Ltd fell for a fifth straight session today. The stock is quoting at Rs 4926.5, down 0.6% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.36% on the day, quoting at 24546.45. The Sensex is at 78526.31, down 0.54%.Torrent Pharmaceuticals Ltd has gained around 1.23% in last one month.Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has increased around 4.18% in last one month and is currently quoting at 26564.8, down 0.27% on the day. The volume in the stock stood at 1.91 lakh shares today, compared to the daily average of 9.09 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 4947.5, down 1.08% on the day. Torrent Pharmaceuticals Ltd jumped 37.87% in last one year as compared to a 0.75% rally in NIFTY and a 23.79% spurt in the Nifty Pharma index.The PE of the stock is 92.08 based on TTM earnings ending June 26.
1 month agoCapital Market - Live
Corporate
Corporate
Ameera Shah concluded her term, stepping down as Independent Director of Torrent PharmaceuticalsTorrent Pharmaceuticals informed the Bombay Stock Exchange and National Stock Exchange that Ameera Shah has ceased to be an Independent Director of the company on August 1, 2026, after completing her term.
1 month agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals announces senior management changes, effective July 30, 2026Torrent Pharmaceuticals informed the Bombay Stock Exchange and National Stock Exchange that Hasmukh Patel, Sushil Jaiswal, and Sunil Nadkarni have ceased to be part of the company's senior management, effective July 30, 2026, due to a change in reporting structure.
1 month agoCapital Market - Live
Earnings
Earnings
Torrent Pharmaceuticals consolidated net profit rises 3.28% in the June 2026 quarterNet profit of Torrent Pharmaceuticals rose 3.28% to Rs 566.00 crore in the quarter ended June 2026 as against Rs 548.00 crore during the previous quarter ended June 2025. Sales rose 54.57% to Rs 4835.00 crore in the quarter ended June 2026 as against Rs 3128.00 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales4835.003128.00 55 OPM %34.4232.99 - PBDT1347.00939.00 43 PBT754.00738.00 2 NP566.00548.00 3 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals appoints Shanti Ekambaram on its boardThe board of Torrent Pharmaceuticals has approved the appointment of Shanti Ekambaram (DIN: 00004889) as an Additional Independent Director of the Company for a term of 3 consecutive years effective from 30 July 2026, subject to approval of the shareholders of the Company.
1 month agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals to conduct board meetingTorrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 July 2026.
2 months agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd spurts 0.67%, up for five straight sessionsTorrent Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 4855.1, up 0.67% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.17% on the day, quoting at 24472.4. The Sensex is at 78420.16, up 0.17%. Torrent Pharmaceuticals Ltd has added around 10.08% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has added around 6.88% in last one month and is currently quoting at 25866.25, down 0.22% on the day. The volume in the stock stood at 3.51 lakh shares today, compared to the daily average of 4.85 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 4858, up 0.58% on the day. Torrent Pharmaceuticals Ltd is up 46.13% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% fall in the Nifty Pharma index.The PE of the stock is 73.79 based on TTM earnings ending March 26.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd soars 2.35%Torrent Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quoting at Rs 4770.9, up 2.35% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.74% on the day, quoting at 24354.25. The Sensex is at 78056.84, up 0.72%. Torrent Pharmaceuticals Ltd has risen around 9.93% in last one month. Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has risen around 6.77% in last one month and is currently quoting at 25308.9, up 2% on the day. The volume in the stock stood at 1.84 lakh shares today, compared to the daily average of 5.05 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 4787.5, up 2.07% on the day. Torrent Pharmaceuticals Ltd is up 41.65% in last one year as compared to a 4.35% drop in NIFTY and a 15.33% drop in the Nifty Pharma index.The PE of the stock is 71.33 based on TTM earnings ending March 26.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Spotlight
Torrent Pharmaceuticals Ltd eases for fifth straight sessionTorrent Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 4426.6, down 0.36% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.13% on the day, quoting at 24116.9. The Sensex is at 77301.67, up 0.19%.Torrent Pharmaceuticals Ltd has eased around 0.75% in last one month.Meanwhile, Nifty Pharma index of which Torrent Pharmaceuticals Ltd is a constituent, has eased around 2.88% in last one month and is currently quoting at 24146.55, up 0.01% on the day. The volume in the stock stood at 1.31 lakh shares today, compared to the daily average of 5.7 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 4443.7, down 0.39% on the day. Torrent Pharmaceuticals Ltd jumped 39.91% in last one year as compared to a 2.73% slide in NIFTY and a 12.63% spurt in the Nifty Pharma index.The PE of the stock is 68.05 based on TTM earnings ending March 26.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Torrent Pharmaceuticals schedules AGMTorrent Pharmaceuticals announced that the 53th Annual General Meeting(AGM) of the company will be held on 23 June 2026.
3 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 18.93%, vs industry avg of 11.78%
Over the last 5 years, market share increased from 2.76% to 3.74%
Over the last 5 years, net income has grown at a yearly rate of 11.56%, vs industry avg of 10.53%